BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 37047226)

  • 1. Receptors and Cofactors That Contribute to SARS-CoV-2 Entry: Can Skin Be an Alternative Route of Entry?
    Barthe M; Hertereau L; Lamghari N; Osman-Ponchet H; Braud VM
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACE2-Independent Alternative Receptors for SARS-CoV-2.
    Lim S; Zhang M; Chang TL
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An improved Fuzzy based GWO algorithm for predicting the potential host receptor of COVID-19 infection.
    Achom A; Das R; Pakray P
    Comput Biol Med; 2022 Dec; 151(Pt A):106050. PubMed ID: 36334362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Term Human Placental Trophoblasts Express SARS-CoV-2 Entry Factors ACE2, TMPRSS2, and Furin.
    Ouyang Y; Bagalkot T; Fitzgerald W; Sadovsky E; Chu T; Martínez-Marchal A; Brieño-Enríquez M; Su EJ; Margolis L; Sorkin A; Sadovsky Y
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33853873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.
    Frolova EI; Palchevska O; Lukash T; Dominguez F; Britt W; Frolov I
    J Virol; 2022 Aug; 96(15):e0075322. PubMed ID: 35876526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
    J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of SARS-CoV-2 receptor proteins in human respiratory tissues identifies alveolar macrophages as potential virus entry site.
    Bräutigam K; Reinhard S; Wartenberg M; Forster S; Greif K; Granai M; Bösmüller H; Klingel K; Schürch CM
    Histopathology; 2023 May; 82(6):846-859. PubMed ID: 36700825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profile of SARS-CoV-2 cellular entry proteins in normal oral mucosa and oral squamous cell carcinoma.
    Sapkota D; Sharma S; Søland TM; Braz-Silva PH; Teh MT
    Clin Exp Dent Res; 2022 Feb; 8(1):117-122. PubMed ID: 34726347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Going viral in the islet: mediators of SARS-CoV-2 entry beyond ACE2.
    Rangu R; Wander PL; Barrow BM; Zraika S
    J Mol Endocrinol; 2022 Jun; 69(2):R63-R79. PubMed ID: 35521990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin L, transmembrane peptidase/serine subfamily member 2/4, and other host proteases in COVID-19 pathogenesis - with impact on gastrointestinal tract.
    Berdowska I; Matusiewicz M
    World J Gastroenterol; 2021 Oct; 27(39):6590-6600. PubMed ID: 34754154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of SARS-CoV-2 Host Cell Entry Factors in Immune System Components of Healthy Individuals and Its Relevance for COVID-19 Immunopathology.
    Kumar A; Kumar S; Narayan RK; Kumari C; Pareek V; Prasoon P
    Viral Immunol; 2021 Jun; 34(5):352-357. PubMed ID: 33481684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classical and alternative receptors for SARS-CoV-2 therapeutic strategy.
    Masre SF; Jufri NF; Ibrahim FW; Abdul Raub SH
    Rev Med Virol; 2021 Sep; 31(5):1-9. PubMed ID: 33368788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell RNA sequencing of SARS-CoV-2 cell entry factors in the preconceptional human endometrium.
    Vilella F; Wang W; Moreno I; Roson B; Quake SR; Simon C
    Hum Reprod; 2021 Sep; 36(10):2709-2719. PubMed ID: 34329437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
    Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z
    Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of host factors in SARS-CoV-2 entry.
    Evans JP; Liu SL
    J Biol Chem; 2021 Jul; 297(1):100847. PubMed ID: 34058196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2.
    Gu Y; Cao J; Zhang X; Gao H; Wang Y; Wang J; He J; Jiang X; Zhang J; Shen G; Yang J; Zheng X; Hu G; Zhu Y; Du S; Zhu Y; Zhang R; Xu J; Lan F; Qu D; Xu G; Zhao Y; Gao D; Xie Y; Luo M; Lu Z
    Cell Res; 2022 Jan; 32(1):24-37. PubMed ID: 34837059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain.
    Torre-Fuentes L; Matías-Guiu J; Hernández-Lorenzo L; Montero-Escribano P; Pytel V; Porta-Etessam J; Gómez-Pinedo U; Matías-Guiu JA
    J Med Virol; 2021 Feb; 93(2):863-869. PubMed ID: 32691890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive Centre Loop Mutagenesis of SerpinB3 to Target TMPRSS2 and Furin: Inhibition of SARS-CoV-2 Cell Entry and Replication.
    Singh S; O'Reilly S; Gewaid H; Bowie AG; Gautier V; Worrall DM
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic Investigation of SARS-CoV-2 Receptor Protein Distribution along Viral Entry Routes in Humans.
    Bräutigam K; Reinhard S; Galván JA; Wartenberg M; Hewer E; Schürch CM
    Respiration; 2022; 101(6):610-618. PubMed ID: 35038715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide CRISPR activation screen identifies candidate receptors for SARS-CoV-2 entry.
    Zhu S; Liu Y; Zhou Z; Zhang Z; Xiao X; Liu Z; Chen A; Dong X; Tian F; Chen S; Xu Y; Wang C; Li Q; Niu X; Pan Q; Du S; Xiao J; Wang J; Wei W
    Sci China Life Sci; 2022 Apr; 65(4):701-717. PubMed ID: 34431042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.